John R Stuelpnagel

Director, 10x Genomics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.4M

Companies

Latest trade

Sep 3, 2026

Companies

10x Genomics, Inc.Director −$2.4M

Trades

TXG Sold 20,000 shares at $61.76 $1.2M Sep 3

TXG Sold 20,000 shares at $57.75 $1.2M Aug 11

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.